Canada: Is This RIP For The "On Sale" Bar (To Harmonize With Other Countries), Or Are Secret Sales Still Prior Art In The U.S.? Helsinn Healthcare S.A. V. Dr. Reddy's Labs., Ltd.

One of the prerequisites of a patentable invention is that it must be new or novel, and in US patent law, the requirements for novelty are found in § 102 of the Patent Statute, much of which addresses actions that are "public" in the sense of putting details of the invention in the public domain. For nearly two centuries this has included a requirement that the invention must not have been "on sale" before a critical date. This provision has been subject to much judicial interpretation, and it is well-settled that it covers "secret" sales that disclose no details of the invention. § 102 has been amended by the America Invents Act (AIA), to add a new provision "otherwise available to the public", sometimes described as a "catchall". It has been a matter of much discussion whether this catchall provision limits the "On Sale" language to exclude "secret" or "non-disclosing" activities.

This recent District Court decision concerned a number of Patents, one of which is found to be an AIA Patent, so the Court had to address the question of whether "secret" or "non-disclosing" sales of the invention before the critical date fall within the redefined scope of prior art in AIA § 102(a) (1).

As a first Decision interpreting this aspect of the AIA statute, the Court held that the "otherwise available to the public" language does indeed modify and restrict the "On Sale" provision to sales and offers for sale that meet the "otherwise available to the public" test, i.e. it does not include "secret" or "non-disclosing" sales. The Decision refers to numerous sources, but the Court appears to have been strongly influenced by the USPTO's own interpretation and guidelines.

Appeal to Federal Circuit

An Appeal has been filed. As nearly one third of the 170 page decision is concerned with an analysis of the "On Sale" bar provision, there appears to be plenty of scope for the Federal Circuit to find fault with the decision, although much of the "On Sale" analysis is concerned with the pre-AIA law. Teva have recently filed their Brief, and two Amicus Briefs has been filed, one by a large group of 42 Intellectual Property law Professors supporting Teva's argument, to the effect that the "On Sale" provision was not changed or limited by the AIA.

Interestingly, while the exact meaning of the key phrase added by the AIA, "otherwise made available to the public", is not discussed or analyzed in detail in the original Decision, the Professors in their Amicus Brief do address this basic question. They argue that the best interpretation is that this defines "a residual category meant to capture all publicly accessible prior art that does not fit into one of the other enumerated categories" and could cover future technology, e.g. a publicly accessible digital file.

The Professors also argue for a "crucial distinction" between "disclosures" and "public disclosures" in AIA §102(b)(1).

The District Court, in its review of the legislative history, relied upon a House Committee Report that incorporated Senate floor statements, but Teva's Appeal Brief notes that one of these was added after the Senate vote on the bill. This has a certain Alice in Wonderland quality; first we pass the bill, then we decide what it means.

What has not been discussed is the change to the heading of § 102 effected by the AIA. The heading now is: CONDITIONS FOR PATENTABILITY; NOVELTY. Pre-AIA, the heading also included:  AND LOSS OF RIGHT. The principle or concept of Loss of Right is valuable and very useful in distinguishing an 'on sale' element of the Section from other pure novelty elements. In particular, the Loss of Right concept applied to an on sale bar inherently; (i) indicates that it applies to the inventor's own actions; and (ii) is based on an entirely different principle from the novelty requirement, so as not to require any aspect of disclosure or communication of enabling information to others.

Public Policy Considerations

The District Court decision notes that, in a first inventor-to-file system, an inventor is adequately incentivized to promptly apply for a patent because the applicant risks having her invention patented by another that may have invented later. It can additionally be noted that limited prior user defenses to infringement should also incentivize prompt filing. Accordingly, there should be no need for prior art to include secret sale activities by the inventor.

However, the holding in this Decision does mean that many inventions can now be commercially exploited outside of the one year grace period without losing patent rights. Further, as some of the sale activities in question were held to be confidential by virtue of a contract, it seems that, for a large class of inventions where commercial use would normally result in disclosure of the invention, patent rights can be reserved by suitable confidentiality provisions in a contract of sale (e.g. sale of a tunneling machine).

Comparison to Novelty Standards in Other Countries

In the AIA, § 102 provides that:

A person shall be entitled to a patent unless – (1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention; or ....

If the "otherwise available to the public" is a governing or overriding element of this provision, then the reference to "patented, described in a printed publication, or in public use, on sale", is merely a non-exclusive list of activities that fall within broad principle of "available to the public", without otherwise being limiting. It therefore seems that this part of § 102 reduces down to:

A person shall be entitled to a patent unless (1) the claimed invention was available to the public before the effective filing date of the claimed invention .....

This language is very similar to that found in novelty standards of many countries. If the District Court's finding on the "On Sale" Bar stands, then this, internationally, is another step in the evolution of a common novelty standard. The mainstream of international patent law favors such an approach and almost identical phrasing can be found in the proposed Substantive Patent Law Treaty. It is attractively simple and one would think that a single, simple test would treat all inventions equally, but this is deceptive.  Setting aside the issue of preserving secrecy by contract, such a test simply has the effect of dividing inventions into those that can be commercially exploited before a critical date and those that cannot; it is further complicated by a small subset of inventions, where commercial exploitation may or may not lead to making the invention "available to the public" depending on how the invention is commercially exploited. (Consider a new machine for making different types of pasta, the pasta being of standard shapes and revealing no details of the machine.)

Despite the observations above, some countries do not consider that an inventor is sufficiently incentivized to file promptly in a first to file system and do retain a "commercial use" provision in their patent law.

For example, in Australia, the Patent Act, 1990, s.18(1)(d) provides:

An invention is a patentable invention ... so far as claimed in any claim: ... was not secretly used in the patent area before the priority date of that claim by, or on behalf of, or with the authority of, the patentee ...

In South Africa, the Novelty Requirements include:

All matter which has been made available to the public anywhere by written or oral description, by use or in any other way before the priority date; 
.....; and

secret use on a commercial scale in South Africa before the priority date.

However, the clear trend internationally is to remove any provision covering commercial use, secret use, or the like. For example, both the United Kingdom in the Patents Act, 1977 and Canada in the Patents Act, 1989 removed provisions that covered, respectively, "secret use" and "on sale". The current provision in the UK law provides that an invention is new if it does not form part of the state of the art, the art comprising all matter which "been made available to the public" before the critical date, and the basic provision in Canadian law requires that the subject matter defined by the claims "must not have been disclosed....in such a manner that the subject matter became available to the public...."  The definitions used both include the "available to the public" standard now incorporated in §102.

Conclusion

Assuming the District Court decision stands, when consulted about an invention that is capable of secret commercial exploitation, the practical advice now must be to include the possibility of practicing the invention in secret. There are few countries where this will prevent a valid patent being obtained, and there are clear dangers in this approach, but it does have the advantages of deferring the cost of filing a patent application and effectively extending the term of a patent. Additionally, when considering a sales contract for patentable technology, consideration should be given to including a confidentiality provision, to preserve patent rights.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.